{
  "id": "ffa647584cc32705",
  "title": "Psyence BioMed Announces Approval for Use of PsyLab Psilocybin Product in Phase IIb Clinical Trial",
  "description": "20251219T131500Z",
  "content": "",
  "source": "manilatimes.net",
  "source_url": "https://www.manilatimes.net/2025/12/19/tmt-newswire/globenewswire/psyence-biomed-announces-approval-for-use-of-psylabs-psilocybin-product-in-phase-iib-clinical-trial/2246949",
  "published_at": "20251219T131500Z",
  "fetched_at": "2025-12-20T00:22:03.659749+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "Philippines",
  "raw_data": {
    "url": "https://www.manilatimes.net/2025/12/19/tmt-newswire/globenewswire/psyence-biomed-announces-approval-for-use-of-psylabs-psilocybin-product-in-phase-iib-clinical-trial/2246949",
    "url_mobile": "https://www.manilatimes.net/2025/12/19/tmt-newswire/globenewswire/psyence-biomed-announces-approval-for-use-of-psylabs-psilocybin-product-in-phase-iib-clinical-trial/2246949/amp",
    "title": "Psyence BioMed Announces Approval for Use of PsyLab Psilocybin Product in Phase IIb Clinical Trial",
    "seendate": "20251219T131500Z",
    "socialimage": "https://www.manilatimes.net/manilatimes/uploads/images/2025/12/19/874450.jpg",
    "domain": "manilatimes.net",
    "language": "English",
    "sourcecountry": "Philippines"
  }
}